TEVA PHARMACEUTICAL INDUSTRIES LTD financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Location
Tel Aviv
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104% % 13%
Quick Ratio 28% % -7.8%
Debt-to-equity 512% % -1%
Return On Equity 11% %
Return On Assets 1.8% %
Operating Margin 11% % 279%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,147,282,512 shares 1.3%
Entity Public Float $18,320,000,000 USD 119%
Common Stock, Value, Issued $58,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 1,147,000,000 shares 1.2%
Weighted Average Number of Shares Outstanding, Diluted 1,164,000,000 shares 2.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $16,776,000,000 USD 0.02%
Selling and Marketing Expense $2,583,000,000 USD 3.3%
General and Administrative Expense $1,221,000,000 USD 6.2%
Operating Income (Loss) $1,827,000,000 USD 279%
Nonoperating Income (Expense) $932,000,000 USD 7.9%
Income Tax Expense (Benefit) $239,000,000 USD -65%
Net Income (Loss) Attributable to Parent $712,000,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,203,000,000 USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current $3,810,000,000 USD 10%
Inventory, Net $3,323,000,000 USD -16%
Other Assets, Current $477,000,000 USD 7.2%
Assets, Current $12,736,000,000 USD 3.4%
Deferred Income Tax Assets, Net $1,634,000,000 USD -21%
Property, Plant and Equipment, Net $4,820,000,000 USD -15%
Operating Lease, Right-of-Use Asset $342,000,000 USD -6%
Goodwill $15,945,000,000 USD -1.1%
Other Assets, Noncurrent $444,000,000 USD -3.3%
Assets $39,856,000,000 USD -4.6%
Accounts Payable, Current $158,000,000 USD 46%
Employee-related Liabilities, Current $561,000,000 USD -9.4%
Liabilities, Current $11,491,000,000 USD -17%
Operating Lease, Liability, Noncurrent $283,000,000 USD -4.1%
Other Liabilities, Noncurrent $3,664,000,000 USD -16%
Liabilities $32,602,000,000 USD -7.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,475,000,000 USD 11%
Retained Earnings (Accumulated Deficit) $14,243,000,000 USD 4.8%
Stockholders' Equity Attributable to Parent $7,250,000,000 USD 20%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7,254,000,000 USD 14%
Liabilities and Equity $39,856,000,000 USD -4.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,066,000,000 USD -43%
Net Cash Provided by (Used in) Financing Activities $2,865,000,000 USD -69%
Net Cash Provided by (Used in) Investing Activities $774,000,000 USD -13%
Common Stock, Shares Authorized 2,495,000,000 shares 0%
Common Stock, Shares, Issued 1,253,000,000 shares 1%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,115,000,000 USD -204%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,203,000,000 USD -34%
Deferred Tax Assets, Valuation Allowance $2,017,000,000 USD -33%
Deferred Tax Assets, Gross $1,799,000,000 USD -0.72%
Operating Lease, Liability $383,000,000 USD -8.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,006,000,000 USD
Lessee, Operating Lease, Liability, to be Paid $495,000,000 USD -0.2%
Property, Plant and Equipment, Gross $8,991,000,000 USD -21%
Operating Lease, Liability, Current $296,000,000 USD -7.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $102,000,000 USD 4.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $120,000,000 USD 3.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 17%
Lessee, Operating Lease, Liability, to be Paid, Year Three $81,000,000 USD 1.2%
Unrecognized Tax Benefits $449,000,000 USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year Four $57,000,000 USD -8.1%
Additional Paid in Capital $28,038,000,000 USD 0.64%
Amortization of Intangible Assets $581,000,000 USD -1.2%